(PharmaNewsWire.Com, July 19, 2017 ) Liver cancer is one of the leading causes of death in European countries. Liver can caused 47 thousands death in Europe in the year 2012.Men are observed to be more prone to liver cancer than women. Due to the rising cases of liver cancer and increasing therapies and technologies advancements, European market is expected to grow during the forecast period.
Directed cancer therapies hamper growth of cancer cells by introducing certain molecules in the body, called molecular targets, hence preventing movement and development of cancer cells. The treatment methods mainly focus on the cellular and molecular variations, affecting precisely to cancer cells.
The drivers that are responsible for the growth of liver cancer therapeutics market are • Increasing consumption of alcohol. • Unmet demands of treating liver cancer therapies. • Technological advancements to develop innovative therapies and products.
For deep understanding Liver Cancer Therapeutics Market is segmented by type, therapeutics and end-user. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Europe liver cancer therapeutics market is segmented on the basis of type into primary, secondary and benign liver growths. On the basis of therapeutics market is bifurcated into hepatocellular carcinoma, Cholangio carcinoma, Hepatoblastoma and targeted therapy. By end-use the market is divided amongst pediatrics and adults. Hepatocellular Carcinoma is the largest segment for therapeutics type due to the high prevalence of this type of liver cancer among people.
Based on geography the market is analyzed under various regions namely, Germany, Italy, Spain, U.K and France. Germany is the leading the market along with UK.
Some of the key contributors in the industry include Alnylam Pharmaceuticals Inc., ImClone Systems Inc., Onyx Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., ArQule Inc., Jennerex Biotherapeutics Inc., Celsion Corp., Bayer Schering Pharma AG, 4SC AG, and Bristol-Myers Squibb Company. Pfizr Inc. holds the most shares in European market.
The Europe Liver Cancer Therapeutics Market report offers wide-range of scope: • Regional and country-level analysis that provides an individual perspective of European region and the aforementioned countries • Know more about key areas of industry growth via detailed Segment-level analysis on basis of type, therapeutic and end-user sector along with market size forecasts and y-o-y estimations • Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics • Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics • Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
